Y. Vlasova

Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review

B. Afanasyev, K. Lepik, E. Morozova, 2015, Biomarker insights.

Conversion from calcineurin inhibitors to sirolimus in transplant‐associated thrombotic microangiopathy

A. Kulagin, A. Vafina, E. Morozova, 2020, Clinical transplantation.

Randomized study between thymoglobulin and posttransplant cyclophosphamide in patients with chronic myeloid neoplasms undergoing unrelated allogeneic stem cell transplantation

I. Moiseev, B. Afanasyev, S. Bondarenko, 2020 .

Graft-versus-host disease prophylaxis with posttransplantation bendamustine (PTB) in patients with refractory acute leukemia: a dose-ranging study: Category of manuscript: Regular Manuscript.

E. Surkova, I. Moiseev, S. Bondarenko, 2021, Transplantation and cellular therapy.

Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors

I. Moiseev, B. Afanasyev, N. Mamaev, 2020, Clinical oncohematology.

COVID-19 infection in hematopoietic stem cell transplant recipients

K. Lepik, S. Bondarenko, M. Popova, 2022, Clinical Microbiology and Antimicrobial Chemotherapy.

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells

N. Barlev, O. Fedorova, O. Shuvalov, 2023, Metabolites.

Epidemiology and impact of colonization by multidrug-resistant Gram-negative bacteria on bloodstream infections in early phase of allogeneic hematopoietic stem cell transplantation

S. Bondarenko, M. Popova, A. Kulagin, 2022, Clinical Microbiology and Antimicrobial Chemotherapy.